Abstract:Objective To investigate the effect of autologous bone marrow-derived endothelial progenitor cell (EPC) transplantation on neurological outcomes in cerebral ischernia in rats and its poss le mechanisms.Methods Autologous bone marrow-derived EPC was cultured in vitro and it was labeled with 5-bromodeoxyuridine (BrdU).A middle cerebral artery occlusion (MCAO) model was induced by the intraluminal suture method.The rats in a EPC group transplanted autologous EPC (106/ml/kg) via external jugular veins,those in a control group were injected with phosphate buffered saline (1 ml/kg),and those in a sham operation group (n =15)were not treated.The modified neurological severity score (mNSS) was used to observe the neurological changes of the rats.BrdU immunohistochemical staining was used to evaluate EPC proliferation and differentiation.Three-dimensional confocal image analysis was used to detect the vascular structure and density in cerebral ischemic areas.TUNEL staining was used to detect the apoptotio cells in ischernic brain tissue.Enzyme-linked immunosorbent assay was used to detect the concentration of plasma vascular endothelial growth factor VEGF).Results The mNSS in the EPC group was siginficantly lower than that in the control group (at day 8:6.43 ±0.69 vs.8.86 ±0.95,q =2.673,P=0.035; at day 14:4.55 ±0.89 vs.6.73 ± 1.06,q =5.360,P =0.035).The number of BrdU positive cells in the EPC group was significantly higher than that in the control group (42.2±5.76 vs.25.67±5.49,q=4.020,P=0.030).The capiilary diameter in the EPC group was significantly smaller than that in the control group (4.51 ± 0.21 μm vs.6.34 ± 0.24 μm,q =3.980,P =0.003); the density of blood vessels (212.64 ± 8.02/0.002 mm3 vs.153.60 ± 7.21/0.002 mm3; q =9.670,P =0.001 ) and the total surface area of microvessel (92 013 ± 5 132 μm2/0.002 mm3 vs. 71 366 ±4 538 μm2/0.002 mm3; q=4.180,P=0.014) were significantly higher or more than those in the control group.The number of apoptotic cells in the EPC group was significantly less than that in the control group (36.26 ± 6.91 vs.78.34 ± 7.21; t =-4.834,P =0.003).The plasma VEGF concentration in the EPC group was significantly higher than that in the control group (54.91 ± 5.71 pg/ml vs.13.81 ± 4.25 pg/ml,q =12.300,P=0.002).Conclusions Autologous EPC transplantation has a protective effect on ischemic brain tissue in rats.It may be associated with VEGF related angiogenesis and neuroprotection.It has an important application prospect in the treatment of ischemic cerebrovascular disease.

Endothelial Progenitor Cell Transplantation Attenuated Synaptic Loss by Enhancing CR3 Dependent Microglial Phagocytosis in Mice

Endothelial Progenitor Cell Transplantation Attenuates Synaptic Loss Associated with Enhancing Complement Receptor 3-Dependent Microglial/macrophage Phagocytosis in Ischemic Mice

Endothelial Progenitor Cell Transplantation Improves Long-Term Stroke Outcome in Mice

Endothelial progenitor cell transplantation alleviated ischemic brain injury via inhibiting C3/C3aR pathway in mice

Autologous Bone Marrow-Derived Endothelial Progenitor Cell Transplantation Improves Neurological Outcomes after Cerebral Ischemia-Reperfusion in Rats

Exogenous Endothelial Progenitor Cells Reached the Deficient Region of Acute Cerebral Ischemia Rats to Improve Functional Recovery Via Bcl-2.

Transplantation of in vitro cultured endothelial progenitor cells repairs the blood-brain barrier and improves cognitive function of APP/PS1 transgenic AD mice

Endothelial Progenitor Cells Improve Functional Recovery in Focal Cerebral Ischemia of Rat by Promoting Angiogenesis Via VEGF.

Infusion of Endothelial Progenitor Cells Accelerates Hematopoietic and Immune Reconstitution, and Ameliorates the Graft-Versus-Host Disease After Hematopoietic Stem Cell Transplantation

The miR-210 Primed Endothelial Progenitor Cell Exosomes Alleviate Acute Ischemic Brain Injury

Endothelial progenitor cell-derived conditioned medium mitigates chronic cerebral ischemic injury through macrophage migration inhibitory factor-activated AKT pathway

cxcl12 -engineered endothelial progenitor cells enhance neurogenesis and angiogenesis after ischemic brain injury in mice

Transplantation of Endothelial Progenitor Cells in the Treatment of Coronary Artery Microembolism in Rats

Abstract 117: Stromal Cell-derived Factor-1 Gene Modified Endothelial Progenitor Cell Effectively Attenuated Ischemic Brain Injury in Mouse Model

Bone Marrow Endothelial Progenitor Cell Transplantation After Ischemic Stroke: An Investigation Into Its Possible Mechanism

Effect of HMGB1 on the Paracrine Action of EPC Promotes Post-Ischemic Neovascularization in Mice.

Constitutive Expression of Adiponectin in Endothelial Progenitor Cells Protects A Rat Model of Cerebral Ischemia

Treatment of acute cerebral ischemia in atherosclerotic rats with autologous transplantation with bone marrow-derived endothelial progenitor cells

Behavioral Studies on the Effect of Endothelial Progenitor Cells on the Spatial Learning and Memory of Chronic Cerebral Ischemic Rats

Dual-modality Imaging of Endothelial Progenitor Cells Transplanted after Ischaemic Photothrombotic Stroke.

Endothelial Progenitor Cells Transplantation Attenuated Blood-Brain Barrier Damage after Ischemia in Diabetic Mice Via HIF-1α